SHANNON TIMOTHY M

CIK 00012071147 companiesNEEDHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001207114

Recent Transactions

50 trades

Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2023-06-07+16,200→ 16,200 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2022-06-16+10,192→ 10,192 total
Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2022-06-09+11,000→ 11,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2022-01-03+6,041→ 6,041 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-07$88.90/sh−5,467→ 1,669,321 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-07$90.75/sh−2,030→ 1,653,128 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-07$87.98/sh−14,751→ 1,674,788 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-07$90.08/sh−14,163→ 1,655,158 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-03$86.39/sh−2,319→ 1,689,539 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-03$85.47/sh−30,068→ 1,691,858 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-02$85.42/sh−28,449→ 1,745,242 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-02$86.34/sh−23,316→ 1,721,926 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-01$85.67/sh−18,821→ 1,834,307 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-01$88.58/sh−11,863→ 1,773,691 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-01$87.86/sh−19,275→ 1,785,554 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-09-01$86.79/sh−29,478→ 1,804,829 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-31$85.39/sh−47,166→ 1,865,317 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-31$86.21/sh−12,189→ 1,853,128 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-30$88.22/sh−1,181→ 1,912,483 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-30$87.51/sh−7,581→ 1,913,664 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-30$86.40/sh−25,469→ 1,921,245 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-30$85.19/sh−24,607→ 1,946,714 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-27$85.38/sh−42,655→ 1,973,692 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-27$86.06/sh−2,371→ 1,971,321 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-26$85.12/sh−11,712→ 2,016,347 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-25$85.03/sh−14,267→ 2,028,059 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-24$87.08/sh−4,635→ 2,042,326 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-24$86.95/sh−4,568→ 2,046,961 total
Sale
ARVINAS, INC.$ARVN
Common Stock
2021-08-23$88.01/sh−1,599→ 2,051,529 total
Purchase
Rallybio Corp$RLYB
Common Stock
2021-08-02$13.00/sh+76,923→ 2,409,712 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2021-07-28+13,440→ 13,440 total
Other
Rallybio Corp$RLYB
Common Stock
2021-07-28+2,332,789→ 2,332,789 total
Other
Rallybio Corp$RLYB
Series A-1 Preferred Units
2021-07-28−1,795,946→ 0 total
Other
Rallybio Corp$RLYB
Series A-2 Preferred Units
2021-07-28−8,742,654→ 0 total
Other
Rallybio Corp$RLYB
Series B Preferred Units
2021-07-28−4,315,676→ 0 total
Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2021-06-10+11,000→ 11,000 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2021-06-08+7,511→ 7,511 total
Purchase
ARVINAS, INC.$ARVN
Common Stock
2020-06-17$30.26/sh+2,000→ 79,546 total
Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2020-06-16+11,000→ 11,000 total
Award
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2020-06-03+12,000→ 12,000 total
Purchase
ARVINAS, INC.$ARVN
Common Stock
2020-06-02$32.30/sh+3,000→ 77,546 total
Exercise/Conversion
ARVINAS, INC.$ARVN
Common Stock
2020-05-26$22.06/sh+12,923→ 74,546 total
Exercise/Conversion
ARVINAS, INC.$ARVN
Stock Option (right to buy)
2020-05-26−12,923→ 0 total
Purchase
ARVINAS, INC.$ARVN
Common Stock
2020-03-20$40.00/sh+2,500→ 61,623 total
Award
IDEAYA Biosciences, Inc.$IDYA
Stock Option (right to buy)
2019-09-24+11,000→ 11,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2019-06-13+22,000→ 22,000 total
Purchase
IDEAYA Biosciences, Inc.$IDYA
Common Stock
2019-05-28$10.00/sh+400,000→ 2,660,713 total
Conversion
IDEAYA Biosciences, Inc.$IDYA
Series A Preferred Stock
2019-05-28−1,658,164→ 0 total
Conversion
IDEAYA Biosciences, Inc.$IDYA
Common Stock
2019-05-28+602,549→ 2,260,713 total
Conversion
IDEAYA Biosciences, Inc.$IDYA
Series B Preferred Stock
2019-05-28−602,549→ 0 total

Companies

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE

NEEDHAM, MA, 02494

View on SEC.gov